Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: ChrisJP who wrote (8767)	7/27/2001 9:08:39 AM
From: zx	Respond to of 208838

Amgen Inc. (NasdaqNM:AMGN - news), the world's largest biotechnology company, late Thursday reported a 6 percent rise in earnings that beat estimates amid solid sales of its anemia drug Epogen and immunity-boosting drug Neupogen. It ended Thursday at $57.72 but its shares jumped to $61.20 in pre-open activity on the Instinet system Friday. VeriSign Inc. (NasdaqNM:VRSN - news) , domain names manager and a provider of e-commerce services, jumped to $52.75 vs. $47.17. After Thursday's close, it reported a second-quarter net loss of $11.2 billion as it wrote down $9.9 billion of the value of acquisitions made near the peak of the Internet boom. Still, on a narrower operating basis its results edged past analysts' expectations.